Dr. GPCR Newsletter November 2022
This past month was busy, to say the least. You can read the full version of the newsletter here. Starting January 2023, you’ll need to sign up for a free site membership to access the contents of the newsletter.
Let's dive into the news.
We are grateful to Domain Therapeutics, GPCR Therapeutics, Design Pharmaceuticals, and Montana Molecular for supporting Dr. GPCR Ecosystem for the next year. If your organization would like to become a partner, reach out to us here.
We are thrilled to partner with the organizers of the GPCR Targeted Drug Discovery Summit for the 2nd edition of this fantastic meeting. Speakers include Drs. Bryan Roth, Thomas P. Sakmar, Graeme Milligan, Sudarshan Rajagopal, Christel Menet, Laurent Sabbagh, Devki Suhktankar, and many more. Join us in person February 21-23, 2023 in Boston.
To explore what the Ecosystem has to offer we recommend you sign-up for free site membership and use the footer to navigate and get acquainted with your virtual playground. When ready, you can sign-up for a premium membership and use Trial50 to get your first year 50% off.
If you’d like to register your lab/team or live in a developing country, please reach out and we will help you join us at a special price.
We’ve had a blast at the Summit this year. We’d like to thank our speakers and poster presenters as well as everyone who attended the Summit.
All speakers received a thank you email and a surprise. In case you can’t find the email in your inbox or spam please take a moment to email us at Hello@DrGPCR.com and we’ll help retrieve your surprise.
We’d love to hear your thoughts about the Summit and kindly ask you to fill out the Survey and enter the raffle to win 1 of 3 Dr. GPCR Ecosystem premium memberships and get full access for FREE for one year. Winners will be picked randomly and you'll be notified by email on January 1st, 2023.
Our next guests include Dr. Chris Langmead, Professor and Deputy Director, Neuromedicines Discovery Centre at Monash University and CEO of Phrenix Therapeutics; Dr. R Scott Struthers, Founder & CEO at Crinetics Pharmaceuticals and Dr. Robert Laprairie, Assistant Professor at the University of Saskatchewan, College of Pharmacy and Nutrition.
As a premium Dr. GPCR Ecosystem member you will be able to watch the video recordings of these episodes and won’t have to wait weeks for the recordings to be made available on various podcast platforms.
1.Interesting papers published in October 2022
1.1 GPCR Activation and Signaling
1.2 Structural and Molecular Insights into GPCR Function
1.3 GPCRs in Oncology and Immunology
1.4 GPCRs in Neuroscience
1.5 GPCRs in Cardiology, Endocrinology & Taste
1.6 Methods and Updates in GPCR Research
1.7 Reviews, GPCRs, and more
1.8 GPCR Binders, Drugs, and more
1.9 Adhesion GPCRs
2.0 Industry news
3.0 Call for papers
Frontiers in Endocrinology, Systems Endocrinology, Advances in Computational and Chemical Methods to study GPCR Signal Transduction. Topic editors, Drs. Enza Lacitiva (University of Bari), Alexey Bondar (Institute of Microbiology, Academy of Sciences of the Czech Republic) & Maria Majellaro (Celtarys Research). Deadline 11/30/2022
Frontiers in Endocrinology, Molecular and Structural, Advanced Biophysical and Biochemical Technologies to study GPCR Signal Transduction. Topic editors, Drs. Enza Lacitiva (University of Bari), Alexey Bondar (Institute of Microbiology, Academy of Sciences of the Czech Republic) & Maria Majellaro (Celtarys Research). Deadline 11/30/2022